197 related articles for article (PubMed ID: 17082321)
21. Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia.
Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Nielsen LV; Johansen PB; Hermit MB; Petersen LC; Mast AE
Proc Natl Acad Sci U S A; 2012 Mar; 109(10):3927-31. PubMed ID: 22355108
[TBL] [Abstract][Full Text] [Related]
22. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages : relationship to tissue factor induction by cholesterol and oxidized LDL.
Petit L; Lesnik P; Dachet C; Moreau M; Chapman MJ
Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):309-15. PubMed ID: 9974412
[TBL] [Abstract][Full Text] [Related]
23. Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.
Winckers K; Thomassen S; Ten Cate H; Hackeng TM
PLoS One; 2017; 12(2):e0168273. PubMed ID: 28158181
[TBL] [Abstract][Full Text] [Related]
24. Heparin-releasable and platelet pools of tissue factor pathway inhibitor in rabbits.
Warn-Cramer BJ; Maki SL; Rapaport SI
Thromb Haemost; 1993 Mar; 69(3):221-6. PubMed ID: 8470044
[TBL] [Abstract][Full Text] [Related]
25. Intrauterine lethality in Tfpi gene disrupted mice is differentially suppressed during mid- and late-gestation by platelet TFPIα overexpression.
Siebert AE; Maroney SA; Martinez ND; Mast AE
J Thromb Haemost; 2021 Jun; 19(6):1483-1492. PubMed ID: 33728763
[TBL] [Abstract][Full Text] [Related]
26. A GPI-anchored co-receptor for tissue factor pathway inhibitor controls its intracellular trafficking and cell surface expression.
Maroney SA; Cunningham AC; Ferrel J; Hu R; Haberichter S; Mansbach CM; Brodsky RA; Dietzen DJ; Mast AE
J Thromb Haemost; 2006 May; 4(5):1114-24. PubMed ID: 16689766
[TBL] [Abstract][Full Text] [Related]
27. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
28. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
Brodin E; Iversen N; Hansen JB
J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
[TBL] [Abstract][Full Text] [Related]
29. Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Tinholt M; Vollan HK; Sahlberg KK; Jernström S; Kaveh F; Lingjærde OC; Kåresen R; Sauer T; Kristensen V; Børresen-Dale AL; Sandset PM; Iversen N
Breast Cancer Res; 2015 Mar; 17(1):44. PubMed ID: 25882602
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor and its inhibition at the human microvascular anastomosis.
Dumanian GA; Heil BV; Khouri RK; Hong C; Labadie K; Wun TC; Johnson PC
J Surg Res; 1996 Jan; 60(1):263-9. PubMed ID: 8592425
[TBL] [Abstract][Full Text] [Related]
31. Post-transcriptional, post-translational and pharmacological regulation of tissue factor pathway inhibitor.
Subramaniam S; Kanse SM; Kothari H; Reinhardt C; Fletcher C
Blood Coagul Fibrinolysis; 2018 Dec; 29(8):668-682. PubMed ID: 30439766
[TBL] [Abstract][Full Text] [Related]
32. Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function.
Soslau G; Morgan DA; Jaffe JS; Brodsky I; Wang Y
Cytokine; 1997 Jun; 9(6):405-11. PubMed ID: 9199874
[TBL] [Abstract][Full Text] [Related]
33. Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells.
Bajaj MS; Pendurthi U; Koenig K; Pueblitz S; Idell S
Eur Respir J; 2000 Jun; 15(6):1069-78. PubMed ID: 10885426
[TBL] [Abstract][Full Text] [Related]
34. Tissue factor pathway inhibitor: new insights into an old inhibitor.
Adams M
Semin Thromb Hemost; 2012 Mar; 38(2):129-34. PubMed ID: 22422327
[TBL] [Abstract][Full Text] [Related]
35. Protein S is a cofactor for tissue factor pathway inhibitor.
Rosing J; Maurissen LF; Tchaikovski SN; Tans G; Hackeng TM
Thromb Res; 2008; 122 Suppl 1():S60-3. PubMed ID: 18691502
[TBL] [Abstract][Full Text] [Related]
36. The heterotrimeric G protein Gβ
Pradhan S; Khatlani T; Nairn AC; Vijayan KV
J Biol Chem; 2017 Aug; 292(32):13133-13142. PubMed ID: 28615442
[TBL] [Abstract][Full Text] [Related]
37. Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms.
Duckers C; Simioni P; Spiezia L; Radu C; Dabrilli P; Gavasso S; Rosing J; Castoldi E
Blood; 2010 Jan; 115(4):879-86. PubMed ID: 19861681
[TBL] [Abstract][Full Text] [Related]
38. Thrombin induces the redistribution and acute release of tissue factor pathway inhibitor from specific granules within human endothelial cells in culture.
Lupu C; Lupu F; Dennehy U; Kakkar VV; Scully MF
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):2055-62. PubMed ID: 7583589
[TBL] [Abstract][Full Text] [Related]
39. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor.
Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M
Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656
[TBL] [Abstract][Full Text] [Related]
40. Do methodological differences account for the current controversy on tissue factor expression in platelets?
Brambilla M; Rossetti L; Zara C; Canzano P; Giesen PLA; Tremoli E; Camera M
Platelets; 2018 Jun; 29(4):406-414. PubMed ID: 28643538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
